Prot# CC-5013-CPRS-002: Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1

Project: Research project

Project Details

StatusFinished
Effective start/end date7/22/05 → 5/21/07

Funding

  • Celgene Corporation (CC-5013-CPRS-002)